Epidermolysis Bullosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial
Conditions: Epidermolysis Bullosa; Pain; Itch Intervention: Drug: AVCN583601 (3% Cannabidiol cream) Sponsors: Elena Pope; Avicanna Inc Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2020 Category: Research Source Type: clinical trials
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa Intervention: Drug: PTR-01 Sponsor: Phoenix Tissue Repair, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials
